The peroxisome proliferator-activated receptor-α （PPAR-α） agonist, AVE8134, attenuates the progressi...
The peroxisome proliferator-activated receptor-α （PPAR-α） agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
Subjects
More information
Scope and Contents
Contents
Aim： To investigate the efficacy of the peroxisome proliferator-activated receptor-α （PPARa） agonist, AVE8134, in cellular and experimental models of cardiac dysfunction and heart failure.
Methods： In Sprague Dawley rats with permanent ligation of the left coronary artery （post-MI）, AVE8134 was compared to the PPARy agonist rosiglitazone and in...
Alternative Titles
Full title
The peroxisome proliferator-activated receptor-α （PPAR-α） agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_chongqing_backfile_30813318
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_chongqing_backfile_30813318
Other Identifiers
ISSN
1671-4083
E-ISSN
1745-7254
